NCT02488473View on ClinicalTrials.gov

Does Perineural Dexmedetomidine Prolong Duration of a Nerve Block?

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Healthy
Interventions
DRUG

Dexmedetomidine

100 ug dexmedetomidine added to the ropivacaine nerveblock

DRUG

Ropivacaine

20 ml Ropivacaine 5mg/ml

DRUG

Isotonic Saline

Placebo

Trial Locations (1)

4600

Department of Anesthesiology Koege Hospital, Koege

All Listed Sponsors
lead

Zealand University Hospital

OTHER

NCT02488473 - Does Perineural Dexmedetomidine Prolong Duration of a Nerve Block? | Biotech Hunter | Biotech Hunter